darunavir has been researched along with piperidine in 2 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (piperidine) | Trials (piperidine) | Recent Studies (post-2010) (piperidine) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 804 | 0 | 323 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cen, S; Dong, B; Ma, L; Wang, J; Wang, Y; Zhang, G; Zhou, H; Zhou, J; Zhu, M | 1 |
| Cen, S; Dong, B; Ma, L; Wang, J; Wang, M; Wang, Y; Zhang, G; Zhou, H; Zhou, J; Zhu, M | 1 |
2 other study(ies) available for darunavir and piperidine
| Article | Year |
|---|---|
Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study.
Topics: Crystallography, X-Ray; Darunavir; Drug Design; Enzyme Inhibitors; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Ligands; Molecular Docking Simulation; Molecular Structure; Piperidines; Structure-Activity Relationship; Sulfonamides | 2020 |
Design and evaluation of novel piperidine HIV-1 protease inhibitors with potency against DRV-resistant variants.
Topics: Anti-HIV Agents; Darunavir; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Structure-Activity Relationship | 2021 |